Sermorelin/Ipamorelin 18 mg/15 mg — Class II drug recall D-1330-2019
Terminated recall by Pharm D Solutions, LLC, reported 2019-06-19, distributed nationwide. Lack of Sterility Assurance.
| Recall number | D-1330-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | FDA mandated |
| Recalling firm | Pharm D Solutions, LLC, Houston, TX, United States |
| Recall initiated | 2019-05-23 |
| Classified | 2019-06-07 |
| Reported by FDA | 2019-06-19 |
| Terminated | 2021-02-05 |
| Distributed | Nationwide (US) |
| Quantity | 24 vials |
| Reason classes | sterility |
| Expiration dates | 2019-10-13, 2019-10-27, 2019-10-29 |
Product
Sermorelin/Ipamorelin 18 mg/15 mg, 10mL vials, Rx only, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054, 1-844-263-6846
Reason for recall
Lack of Sterility Assurance.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1330-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.